IPOs in global biopharma industry rise to $8.52 billion in 2024 –...

IPOs in global biopharma industry rise to $8.52 billion in 2024 –...

Last Updated on April 19, 2025 by Team THIP New Delhi, April 19 (IANS) The initial public offerings (IPOs) in the biopharmaceutical sector surged 68.4 per cent to reach $8.52 billion globally in 2024, according to a new report. The sector saw an upturn in 2024, with 50 completed IPOs raising $8.52 billion, from $5.06 […] The post IPOs in global biopharma industry rise to $8.52 billion in 2024 appeared first on THIP Media.

Biotech IPOs surge 68.4% YoY to $8.52 billion in 2024 amid public market recovery, reveals GlobalData

Biopharmaceutical initial public offerings (IPOs) saw an upturn in 2024, with 50 completed IPOs raising $8.52 billion, a 68.4% increase from the $5.06 billion raised in 2023 and marking the highest total IPO value raised since 2021. This rebound, driven by US Federal Reserve interest rate cuts, marks the highest total since 2021. While cautious, investors are showing increased interest in companies with strong clinical data, signaling a recovery…